Development of CAR T cell therapy targeting glypican-3 in liver cancer

被引：0

作者：

Dan Li ^{[1
]}

Nan Li ^{[1
]}

Yifan Zhang ^{[1
]}

Haiying Fu ^{[1
]}

Madeline B.Torres ^{[1
]}

Tim F.Greten ^{[1
]}

Mitchell Ho ^{[1
]}

机构：

[1] Center for Cancer Research, National Cancer Institute

来源：

Cancer Biology & Medicine | 2018年 / S1期

关键词：

HCC; GPC; Development of CAR T cell therapy targeting glypican-3 in liver cancer;

D O I：

暂无

中图分类号：

R735.7 [肝肿瘤];

学科分类号：

100214 ;

摘要：

Objective:Glypican-3(GPC3)is a promising therapeutic target in hepatocellular carcinoma(HCC).We have generated the HN3 and h YP7 antibodies that recognize the N-lobe and C-lobe of GPC3,respectively.Here,we engineered human T cells that express GPC3-specific chimeric antigen receptors(CARs)and evaluated their potential for the treatment of HCC.

引用

页码：17 / 17

页数：1

共 50 条

[1] Development of CAR T-cell therapy targeting glypican-3 in liver cancer
Li, Dan
Li, Nan
Zhang, Yifan
Fu, Haiying
Torres, Madeline B.
Wang, Qun
Greten, Tim F.
Ho, Mitchell
[J]. CANCER RESEARCH, 2018, 78 (13)
[2] A CAR-T CELL THERAPY TARGETING GLYPICAN-3 POSITIVE HEPATOCELLULAR CARCINOMA
Wang, B.
Ngoh, E.
Soh, M. K.
Yeap, Y.
Huang, H.
Tan, H. C.
Hu, Y.
Wang, C. I.
[J]. HUMAN GENE THERAPY, 2018, 29 (11) : A16 - A16
[3] Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update
Fleming, Bryan D.
Ho, Mitchell
[J]. BIOMOLECULES, 2020, 10 (06) : 1 - 16
[4] Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer
Fleming, Bryan D.
Ho, Mitchell
[J]. TOXINS, 2016, 8 (10):
[5] Engineering glypican-3 targeting immunotoxins for the treatment of liver cancer
Fleming, Bryan D.
Nixon, Brittany
Pastan, Ira
Ho, Mitchell
[J]. CANCER RESEARCH, 2017, 77
[6] Glypican-3 Targeting of Liver Cancer Cells Using Multifunctional Nanoparticles
Park, James O.
Stephen, Zachary
Sun, Conroy
Veiseh, Omid
Kievit, Forrest M.
Fang, Chen
Leung, Matthew
Mok, Hyejung
Zhang, Miqin
[J]. MOLECULAR IMAGING, 2011, 10 (01): : 69 - 77
[7] Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy
Wang, Chunguang
Gao, Wei
Feng, Mingqian
Pastan, Ira
Ho, Mitchell
[J]. ONCOTARGET, 2017, 8 (20) : 32450 - 32460
[8] Next-Generation Cancer Immunotherapy Targeting Glypican-3
Shimizu, Yasuhiro
Suzuki, Toshihiro
Yoshikawa, Toshiaki
Endo, Itaru
Nakatsura, Tetsuya
[J]. FRONTIERS IN ONCOLOGY, 2019, 9
[9] Glypican-3 immunohistochemistry precision, validation, and prevalence in selected solid tumors to identify target populations for CAR T cell therapy
Weiss, Glen J.
Jensen-Smith, Amy
Muralidharan, Sujatha
[J]. CANCER RESEARCH, 2022, 82 (12)
[10] Inhibition of Glypican-3 Cleavage Results in Reduced Cell Proliferation in a Liver Cancer Cell Line
Schepers, Emily J.
Lake, Charissa
Glaser, Kathryn
Bondoc, Alexander J.
[J]. JOURNAL OF SURGICAL RESEARCH, 2023, 282 : 118 - 128

← 1 2 3 4 5 →